Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 05 2021
21 05 2021
Historique:
received:
21
09
2020
accepted:
25
03
2021
entrez:
22
5
2021
pubmed:
23
5
2021
medline:
4
11
2021
Statut:
epublish
Résumé
Systemic sclerosis (SSc) is a potentially serious and disabling connective tissue disease specially in case of interstitial lung disease (SSc-ILD). The aim of our study was to evaluate the potential utility of dosing in the induced sputum (IS) and to compare their levels in SSc-ILD and SSc-nonILD patients, as well as in healthy volunteers (HV). IS and sera values were also compared. In a prospective cross-sectional analysis, we studied the IS and serum provided from 25 SSc patients, 15 SSc-nonILD and 10 SSc-ILD, compared to 25 HV. We analyzed sputum cell composition and quantified in the supernatant and corresponding serum by commercially available immunoassays: IGFBP-1, IGFBP-2, IGFBP-3, TGF-β, IL-8, TNF-α, YKL-40, MMP-7 and MMP-9. Lung function was studied by the determination of FEV-1 (%), FVC (%), DLCO (%) and KCO (%). The IS of SSc patients had a lower weight than HV (p<0.05, p<0.01) without any significant difference with regard to the cellularity. IGFBP-1 (p < 0.0001), TGF-β (p < 0.05), IL-8 (p < 0.05), YKL-40 (p < 0.0001) and MMP-7 (p < 0.01) levels were increased in the IS of SSc patients compared to HV. Only IL-8 serum levels (p < 0.001) were increased in SSc patients compared to HV. Neither in IS nor in serum were observed differences between SSc-ILD and SSc-nonILD patients. Correlations were observed between IS IL-8 levels and FEV-1 (%) (r = = - 0.53, p < 0.01), FVC (%) (r = - 0.51, p < 0.01) and annualized ∆KCO (%) (r = 0.57, p < 0.05), between IS TGF-β levels and annualized ∆FEV-1 (%) (r = = - 0.57, p < 0.05), between IS IGFBP-2 levels and annualized ∆KCO (%) (r = 0.56, p < 0.05). Our study showed that SSc patients exhibit raised IS levels of IGFBP-1, TGF-β, IL-8, YKL-40 and MMP-7, molecules known to be involved in lung remodeling and fibrotic process, without any significant difference between SSc-ILD and SSc-nonILD patients. IL-8, TGF-β and IGFBP-2 are correlated with lung function in SSc patients which emphasize clinical relevance. IS analysis represents a new approach to understand lung inflammatory process in SSc patients. A longitudinal study is needed to evaluate their pathophysiological relevance.
Identifiants
pubmed: 34021175
doi: 10.1038/s41598-021-87701-1
pii: 10.1038/s41598-021-87701-1
pmc: PMC8139955
doi:
Substances chimiques
Biomarkers
0
Cytokines
0
Inflammation Mediators
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10679Références
Oncogene. 2009 Dec 17;28(50):4456-68
pubmed: 19767768
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Respir Med. 2011 Jan;105(1):106-13
pubmed: 20888745
Rheumatology (Oxford). 2019 Sep 1;58(9):1534-1546
pubmed: 31292645
Arthritis Rheum. 2000 Feb;43(2):444-51
pubmed: 10693887
Respir Care. 2016 Oct;61(10):1369-73
pubmed: 27274093
Int J Mol Sci. 2020 May 19;21(10):
pubmed: 32438606
Thorax. 1992 Sep;47(9):738-42
pubmed: 1440471
Chest. 2020 Aug;158(2):646-659
pubmed: 32268131
Respir Med. 2010 Aug;104(8):1204-10
pubmed: 20347285
J Vis Exp. 2017 Dec 17;(130):
pubmed: 29286433
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
Rheumatol Int. 2012 Jul;32(7):1921-5
pubmed: 21448645
Arthritis Res Ther. 2009;11(4):R111
pubmed: 19615053
J Cell Commun Signal. 2015 Jun;9(2):125-42
pubmed: 25617050
Arthritis Rheum. 2007 Jun;56(6):2005-12
pubmed: 17530640
Radiology. 1990 Sep;176(3):755-9
pubmed: 2389033
Eur Respir J. 2017 Feb 23;49(2):
pubmed: 27836954
Chest. 2009 Nov;136(5):1211-1219
pubmed: 19429720
Atherosclerosis. 2010 Jun;210(2):590-5
pubmed: 20056225
Rheum Dis Clin North Am. 2015 May;41(2):237-48
pubmed: 25836640
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):55-61
pubmed: 24751454
Am J Respir Crit Care Med. 1995 Jul;152(1):53-8
pubmed: 7599862
Eur Respir J. 2005 Nov;26(5):948-68
pubmed: 16264058
Curr Opin Rheumatol. 2005 Nov;17(6):737-45
pubmed: 16224252
Exp Dermatol. 2011 Sep;20(9):770-3
pubmed: 21707759
Chest. 2008 May;133(5):1101-6
pubmed: 18071010
Arthritis Rheumatol. 2014 Aug;66(8):1967-78
pubmed: 24838199
Eur Respir J. 2010 Jan;35(1):112-7
pubmed: 19541715
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):762-8
pubmed: 9517588
Sarcoidosis Vasc Diffuse Lung Dis. 2003 Jun;20(2):138-43
pubmed: 12870724
Med Sci (Paris). 2016 Feb;32(2):183-91
pubmed: 26936176
Respiration. 2009;78(1):56-62
pubmed: 18931474
BMC Pediatr. 2018 Dec 4;18(1):381
pubmed: 30514252
Rev Med Liege. 2019 Jan;74(1):47-53
pubmed: 30680974
BMC Pulm Med. 2016 May 23;16(1):86
pubmed: 27215343
J Rheumatol. 2001 Jul;28(7):1573-6
pubmed: 11469464
Lung. 2017 Jun;195(3):273-280
pubmed: 28353114
PLoS One. 2017 Feb 8;12(2):e0171344
pubmed: 28178340
Proc Am Thorac Soc. 2012 Jul;9(3):111-6
pubmed: 22802283
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):228-36
pubmed: 26422568
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Rev Med Liege. 2019 Mar;74(3):139-145
pubmed: 30897313
PLoS One. 2016 May 09;11(5):e0154516
pubmed: 27159038
Int J Mol Sci. 2017 Dec 16;18(12):
pubmed: 29258183
Lab Invest. 1999 Nov;79(11):1403-13
pubmed: 10576211
Semin Arthritis Rheum. 2010 Feb;39(4):269-77
pubmed: 18706680
J Rheumatol. 2016 Sep;43(9):1672-9
pubmed: 27370878
N Engl J Med. 2019 Jun 27;380(26):2518-2528
pubmed: 31112379
Lancet Respir Med. 2020 May;8(5):453-460
pubmed: 32145830
Int J Chron Obstruct Pulmon Dis. 2018 Jan 30;13:409-418
pubmed: 29430175
Arthritis Rheum. 2009 Feb;60(2):569-77
pubmed: 19180517
Rev Med Liege. 2020 May;75(5-6):344-349
pubmed: 32496677
Chest. 2008 Sep;134(3):601-605
pubmed: 18403656
Gen Comp Endocrinol. 2005 May 15;142(1-2):44-52
pubmed: 15862547
Ann Rheum Dis. 2003 Feb;62(2):97-9
pubmed: 12525376
Am J Respir Crit Care Med. 2005 Aug 1;172(3):268-79
pubmed: 15879420
Clin Epigenetics. 2017 Aug 15;9:84
pubmed: 28824731
Ann Rheum Dis. 2008 Jan;67(1):110-6
pubmed: 17557890
Arthritis Rheum. 2007 Mar 15;57(2):318-26
pubmed: 17330281
J Clin Endocrinol Metab. 2011 Jan;96(1):200-9
pubmed: 20943784